Les Dutton, Ph.D., will be awarded the 2013 John Scott Award next week. He will be honored with a medal, certificate, and $12,000 for his "work on the elementary processes of oxidation-reduction and the diverse biological events coupled to it." Dutton is the Eldridge Reeves Johnson Professor of Biochemistry and Biophysics, the director of the Johnson Foundation for Molecular Biophysics, a Fellow of the Royal Society, and former chair of the Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania. And an accomplished artist, but more on that later.
Patients with tumors that contain increased numbers of T lymphocytes generally survive longer than those with tumors without T-cell involvement, suggesting that T cells with potent antitumor function naturally exist in cancer and control tumor progression. With the exception of melanoma, it has been difficult to identify and isolate the tumor-reactive T cells from common cancers, however, the ability to do so could be used to fight a patient’s own cancer.
Clearly, interest in career issues for postdocs is not new, but ways to expand the postdoc experience to ready for budding careers takes constant creativity and communication. To that end, the Biomedical Postdoctoral Council at the Perelman School of Medicine, University of Pennsylvania, held its 12th annual Postdoctoral Research Symposium last week.
With this zoomed-in view, the Abramson Family Cancer Research Institute (AFCRI) lab of Celeste Simon, PhD, and postdoctoral fellow, T.S. Karin Eisinger-Mathason PhD, report in Cancer Discovery about the potential of the collagen-modifying enzyme PLOD2 as a new therapeutic target for the treatment of metastatic undifferentiated pleomorphic sarcoma.
An article in the Wall Street Journal this week highlights ongoing research at Penn Medicine looking at a new way to use ventricular assist devices (VADs) for heart failure patients. This same research was also featured in the article “Rest, Recovery, Reconditioning” in a recent edition of Penn Medicine’s System...
Following a briefing on the current state of neuroscience research across the United States, held in Philadelphia's University City Science Center and hosted by Congressman Chaka Fattah, we had the opportunity to take the morning's featured speaker, Dr. Philip Rubin, Principal Assistant Director for Science at The White House Office of Science and Technology Policy (OSTP), on a whirlwind tour of brain-related research here at Penn Medicine.
Penn’s Institute on Aging recently co-hosted its annual Sylvan M. Cohen lecture and poster session. This year, in partnership with the Abramson Cancer Center‘s Tumor Biology Program, the event focused on “protecting the genome in the longevity revolution: cancer and aging.” Brian Duke, Pennsylvania Secretary for Aging, set the stage...
I hold the publication in my hands. It features an article on “chronobiology” and sleep studies. It includes some faculty newsmakers, such as Albert J. Stunkard, MD, professor of Psychiatry, one of Penn’s well-known experts on sleep disorders; Peter Quinn, DMD, MD, a leader in surgically treating the most painful...
Angelina Jolie’s Cancer Prevention Surgery Puts Basser Research Center for BRCA In National Spotlight
Basser.graphic.blue.background.expanded This week, when Oscar-winning actress and humanitarian Angelina Jolie revealed that she underwent surgery to remove her breasts after learning that she carries one of the BRCA gene mutations that put her at high risk of developing breast and ovarian cancer, the news hit home here at the University of Pennsylvania. Just a year ago, Penn announced the creation of the Basser Research Center for BRCA, which was made possible by a $25 million gift from Penn alums Mindy and Jon Gray, in honor of Mindy Gray’s sister, Faith Basser, who died of ovarian cancer at age 44. As the only center in the United States devoted solely to research on prevention and treatment for cancers related to BRCA mutations, Jolie’s story turned a spotlight on the important work in progress there, and the experiences of the many other families with similar cancer risks.
In an online video series, Florie Charles, a doctoral student at the University of California at San Francisco, and founder of Youreka Science, simply uses a white board and colored markers (and occasionally a small cut out mouse -- animal, not computer peripheral) to explain findings from recent papers in an accessible, fresh, and engaging way. One of her newest videos happens to feature a recent publication from the lab of Garret FitzGerald, MD, FRS, director of Penn Medicine's Institute of Translational Medicine and Therapeutics.
To show its gratitude to all laboratory professionals, the department of Pathology and Laboratory Medicine celebrated Medical Laboratory Professionals Week April 22-26, with a host of activities, such as Phillies Night, in appreciation of all the hard work and dedication of the hundreds of staff and faculty members working in more than 30 different laboratories across the Penn campus.
Can sleeping actually make you MORE tired? For many patients with obstructive sleep apnea (OSA), they awake each morning thinking they had a full night’s rest, only to feel exhausted and unfocused day after day. This counterintuitive situation occurs because OSA sufferers may wake up dozens of times an hour...
“We Found a Change In Your DNA And We Don’t Know What it Means” – Questions and Challenges in the Era of Massively Parallel Gene Sequencing
Women who develop breast cancer while they’re young are often searching for answers about the cause for their disease or what they can do to improve their chances of being cured. While an increasing number of large genetic testing panels promise to scrutinize their DNA to uncover clues, a team of researchers from the Perelman School of Medicine and the Abramson Cancer Center has found that those powerful tests tend to produce more questions than they answer.